DSIJ Mindshare

Key indices made optimistic start, as investors took some encouragement after India jumped 14 places to the 63rd position on the World Bank's ease of doing business ranking, riding high on the government's flagship Make in India scheme and other reforms attracting foreign investment.

Alembic Pharmaceuticals announced that its joint venture named Aleor Dermaceuticals received approval for Desonide Ointment, 0.05 per cent from USFDA.

Bharat Sanchar Nigam Limited (BSNL) sees this as a very important step from the government. According to the latest published financial numbers by the company, its net loss stood Rs. 8000 crore in fiscal 2018 while MTNL, for FY19, reported net loss of Rs. 3390 crore.

Aurobindo Pharma has informed the exchanges on receiving final approval from the US Food & Drug Administration (USFDA) for Guaifenesin tablets.